These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 16304192

  • 1. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K, Tredup A, Salvenmoser S, Müller FM.
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [Abstract] [Full Text] [Related]

  • 2. Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
    Lewis RE, Kontoyiannis DP.
    J Antimicrob Chemother; 2005 Nov; 56(5):887-92. PubMed ID: 16188916
    [Abstract] [Full Text] [Related]

  • 3. In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.
    Yustes C, Guarro J.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3498-500. PubMed ID: 16048969
    [Abstract] [Full Text] [Related]

  • 4. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A.
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [Abstract] [Full Text] [Related]

  • 5. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S.
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [Abstract] [Full Text] [Related]

  • 6. Determination of MICs of aminocandin for Candida spp. and filamentous fungi.
    Isham N, Ghannoum MA.
    J Clin Microbiol; 2006 Dec; 44(12):4342-4. PubMed ID: 17021057
    [Abstract] [Full Text] [Related]

  • 7. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
    [Abstract] [Full Text] [Related]

  • 8. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis RE, Wiederhold NP, Klepser ME.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
    [Abstract] [Full Text] [Related]

  • 9. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Gilgado F, Serena C, Cano J, Gené J, Guarro J.
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4211-3. PubMed ID: 17015631
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activity of micafungin combined with itraconazole against Candida spp.
    Mariné M, Serena C, Pastor J, Quindós G, Carrillo AJ, Guarro J.
    Int J Antimicrob Agents; 2007 Nov; 30(5):463-5. PubMed ID: 17698327
    [Abstract] [Full Text] [Related]

  • 12. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
    Guinea J, Peláez T, Recio S, Torres-Narbona M, Bouza E.
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1396-400. PubMed ID: 18212101
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
    Miyazaki M, Horii T, Hata K, Watanabe NA, Nakamoto K, Tanaka K, Shirotori S, Murai N, Inoue S, Matsukura M, Abe S, Yoshimatsu K, Asada M.
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4652-8. PubMed ID: 21825291
    [Abstract] [Full Text] [Related]

  • 14. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA.
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
    Pearce JW, Giuliano EA, Moore CP.
    Vet Ophthalmol; 2009 Feb; 12(5):318-24. PubMed ID: 19751493
    [Abstract] [Full Text] [Related]

  • 16. Voriconazole: a new triazole antifungal agent.
    Johnson LB, Kauffman CA.
    Clin Infect Dis; 2003 Mar 01; 36(5):630-7. PubMed ID: 12594645
    [Abstract] [Full Text] [Related]

  • 17. In vitro interactions of itraconazole and micafungin against clinically important filamentous fungi.
    Ruíz-Cendoya M, Rodriguez MM, Mariné M, Pastor FJ, Guarro J.
    Int J Antimicrob Agents; 2008 Nov 01; 32(5):418-20. PubMed ID: 18762407
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.
    Laverdiere M, Hoban D, Restieri C, Habel F.
    J Antimicrob Chemother; 2002 Jul 01; 50(1):119-23. PubMed ID: 12096017
    [Abstract] [Full Text] [Related]

  • 19. Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method.
    Pai MP, Jones AL, Mullen CK.
    Diagn Microbiol Infect Dis; 2007 May 01; 58(1):129-32. PubMed ID: 17240112
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P, Shapiro BL, Srinivasan M, Prajna NV, Acharya NR, Fothergill AW, Ruiz J, Chidambaram JD, Maxey KJ, Hong KC, McLeod SD, Lietman TM.
    Arch Ophthalmol; 2007 Jun 01; 125(6):789-93. PubMed ID: 17562990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.